AgeX Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 22, 2024
SER$1.43+3.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Part I
References to “ AgeX,” “our” or “us” mean AgeX Therapeutics, Inc.
In this Annual Report on Form 10-K, the description or discussion of any contract or agreement is a summary only and is qualified in all respects by reference to the full text of the applicable contract or agreement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.